Chenzhou Hao

756 total citations
29 papers, 563 citations indexed

About

Chenzhou Hao is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Chenzhou Hao has authored 29 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Organic Chemistry. Recurrent topics in Chenzhou Hao's work include Protein Kinase Regulation and GTPase Signaling (7 papers), Cancer Mechanisms and Therapy (5 papers) and Melanoma and MAPK Pathways (5 papers). Chenzhou Hao is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (7 papers), Cancer Mechanisms and Therapy (5 papers) and Melanoma and MAPK Pathways (5 papers). Chenzhou Hao collaborates with scholars based in China, United States and Denmark. Chenzhou Hao's co-authors include Maosheng Cheng, Tianxiao Wu, Shizhen Zhao, Dongmei Zhao, Liyu Zhao, Chunchi Liu, Dongmei Zhao, Dongmei Zhao, Sijia Yu and Wei Peng and has published in prestigious journals such as Nature Chemical Biology, Molecules and European Journal of Medicinal Chemistry.

In The Last Decade

Chenzhou Hao

29 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenzhou Hao China 15 298 259 123 69 64 29 563
Andrei W. Konradi United States 14 328 1.1× 298 1.2× 63 0.5× 23 0.3× 24 0.4× 27 754
Tianxiao Wu China 16 198 0.7× 329 1.3× 133 1.1× 34 0.5× 27 0.4× 35 510
Laxman Nallan United States 11 137 0.5× 285 1.1× 57 0.5× 40 0.6× 71 1.1× 11 544
Rongze Kuang United States 16 320 1.1× 280 1.1× 105 0.9× 26 0.4× 22 0.3× 27 592
Gurubasavaraja Swamy Purawarga Matada India 16 332 1.1× 182 0.7× 114 0.9× 16 0.2× 73 1.1× 53 551
Matthew E. Voss United States 14 274 0.9× 281 1.1× 134 1.1× 15 0.2× 26 0.4× 22 708
Vincent Galullo United States 10 229 0.8× 468 1.8× 182 1.5× 63 0.9× 90 1.4× 10 724
Anton Cheltsov United States 13 121 0.4× 338 1.3× 105 0.9× 42 0.6× 60 0.9× 19 640
Hajjaj H.M. Abdu-Allah Egypt 17 462 1.6× 303 1.2× 70 0.6× 27 0.4× 38 0.6× 45 684
Anthony R. Gangloff United States 12 322 1.1× 362 1.4× 108 0.9× 18 0.3× 41 0.6× 16 627

Countries citing papers authored by Chenzhou Hao

Since Specialization
Citations

This map shows the geographic impact of Chenzhou Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenzhou Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenzhou Hao more than expected).

Fields of papers citing papers by Chenzhou Hao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenzhou Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenzhou Hao. The network helps show where Chenzhou Hao may publish in the future.

Co-authorship network of co-authors of Chenzhou Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Chenzhou Hao. A scholar is included among the top collaborators of Chenzhou Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenzhou Hao. Chenzhou Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hao, Chenzhou, Chao Gao, Michiel Hageman, et al.. (2025). Pharmacodynamics of Akt drugs revealed by a kinase-modulated bioluminescent indicator. Nature Chemical Biology. 21(8). 1194–1204. 1 indexed citations
2.
Chen, Rui, et al.. (2023). Development of a cell-permeable adenine-derived probe for capture of nucleotide-binding proteins in living cells. Chinese Chemical Letters. 35(3). 108455–108455. 1 indexed citations
3.
Hao, Chenzhou, et al.. (2023). Optically activated MEK1/2 inhibitors (Opti-MEKi) as potential antimelanoma agents. European Journal of Medicinal Chemistry. 251. 115236–115236. 4 indexed citations
4.
Wu, Tianxiao, Ruicheng Lv, Nian Liu, et al.. (2022). Discovery of quinazoline derivatives CZw-124 as a pan-TRK inhibitor with potent anticancer effects in vitro and in vivo. European Journal of Medicinal Chemistry. 238. 114451–114451. 18 indexed citations
5.
Wang, Ruifeng, Sijia Yu, Yixuan Chen, et al.. (2020). Discovery of 7H-pyrrolo[2,3-d]pyridine derivatives as potent FAK inhibitors: Design, synthesis, biological evaluation and molecular docking study. Bioorganic Chemistry. 102. 104092–104092. 24 indexed citations
6.
Wang, Ruifeng, Yixuan Chen, Bowen Yang, et al.. (2019). Design, synthesis, biological evaluation and molecular modeling of novel 1H-pyrrolo[2,3-b]pyridine derivatives as potential anti-tumor agents. Bioorganic Chemistry. 94. 103474–103474. 24 indexed citations
7.
Wang, Ruifeng, Yixuan Chen, Sijia Yu, et al.. (2019). Design, synthesis and biological evaluation of novel 7H-pyrrolo[2,3-d]pyrimidine derivatives as potential FAK inhibitors and anticancer agents. European Journal of Medicinal Chemistry. 183. 111716–111716. 35 indexed citations
8.
Wang, Ruifeng, Sijia Yu, Yixuan Chen, et al.. (2019). Design, synthesis, biological evaluation and molecular docking study of novel thieno[3,2-d]pyrimidine derivatives as potent FAK inhibitors. European Journal of Medicinal Chemistry. 188. 112024–112024. 47 indexed citations
9.
Guo, Jing, Tingting Wang, Tianxiao Wu, et al.. (2019). Synthesis, bioconversion, pharmacokinetic and pharmacodynamic evaluation of N-isopropyl-oxy-carbonyloxymethyl prodrugs of CZh-226, a potent and selective PAK4 inhibitor. European Journal of Medicinal Chemistry. 186. 111878–111878. 12 indexed citations
10.
Guo, Jing, Wenbo Yin, Mingyue Zhu, et al.. (2018). Design, synthesis, structure-activity relationships study and X-ray crystallography of 3-substituted-indolin-2-one-5-carboxamide derivatives as PAK4 inhibitors. European Journal of Medicinal Chemistry. 155. 197–209. 26 indexed citations
11.
Zhao, Shizhen, Wei Peng, Xin Su, et al.. (2017). Design, synthesis and evaluation of aromatic heterocyclic derivatives as potent antifungal agents. European Journal of Medicinal Chemistry. 137. 96–107. 45 indexed citations
12.
Guo, Jing, Mingyue Zhu, Tianxiao Wu, et al.. (2017). Discovery of indolin-2-one derivatives as potent PAK4 inhibitors: Structure-activity relationship analysis, biological evaluation and molecular docking study. Bioorganic & Medicinal Chemistry. 25(13). 3500–3511. 30 indexed citations
13.
Hao, Chenzhou, Wanxu Huang, Xiaodong Li, et al.. (2017). Development of 2, 4-diaminoquinazoline derivatives as potent PAK4 inhibitors by the core refinement strategy. European Journal of Medicinal Chemistry. 131. 1–13. 21 indexed citations
14.
Zhang, Hongyan, Jian Zhang, Chenzhou Hao, et al.. (2017). LC-0882 targets PAK4 and inhibits PAK4-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells.. PubMed. 9(6). 2736–2747. 17 indexed citations
15.
Liu, Chunchi, Qiong Wu, Shizhen Zhao, et al.. (2016). Design, synthesis and biological evaluation of novel cholesteryl ester transfer protein inhibitors bearing a cycloalkene scaffold. European Journal of Medicinal Chemistry. 123. 419–430. 4 indexed citations
16.
Li, Yiqun, Ruifeng Wang, Chunchi Liu, et al.. (2016). Discovery of novel N,N-3-phenyl-3-benzylaminopropionanilides as potent inhibitors of cholesteryl ester transfer protein in vivo. Bioorganic & Medicinal Chemistry. 24(8). 1811–1818. 4 indexed citations
17.
Zhao, Dongmei, Shizhen Zhao, Liyu Zhao, et al.. (2016). Discovery of biphenyl imidazole derivatives as potent antifungal agents: Design, synthesis, and structure-activity relationship studies. Bioorganic & Medicinal Chemistry. 25(2). 750–758. 52 indexed citations
18.
Zhao, Dongmei, Chunchi Liu, Chenzhou Hao, et al.. (2015). Design, synthesis and biological evaluation of N,N-3-phenyl-3-benzylaminopropanamide derivatives as novel cholesteryl ester transfer protein inhibitor. Bioorganic & Medicinal Chemistry. 24(8). 1589–1597. 9 indexed citations
19.
Zhao, Dongmei, Bin Sun, Jinhong Ren, et al.. (2015). Synthesis and biological evaluation of 3-phenyl-3-aryl carboxamido propanoic acid derivatives as small molecule inhibitors of retinoic acid 4-hydroxylase (CYP26A1). Bioorganic & Medicinal Chemistry. 23(6). 1356–1365. 13 indexed citations
20.
Sun, Bin, Shuai Song, Chenzhou Hao, et al.. (2014). Molecular recognition of CYP26A1 binding pockets and structure–activity relationship studies for design of potent and selective retinoic acid metabolism blocking agents. Journal of Molecular Graphics and Modelling. 56. 10–19. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026